Clinician differences in attitudes and perceptions on the use of long-acting injectable antipsychotic agents in treating patients with schizophrenia: results from the US DECIDE survey
These results indicate that multiple factors (e.g., environmental/demographic factors, access, attitudes, motivation, knowledge/confidence) combine to influence LAI use, and highlight the need to tailor educational materials aimed at improving patient outcomes through increased LAI use.
Authors
- Stephen Thompson (ORCID: https://orcid.org/0000-0001-9637-2041)
- Gregory D. Salinas (ORCID: https://orcid.org/0000-0001-8261-699X)
- Richard Hansen (ORCID: https://orcid.org/0000-0002-3944-6646)
- Emily Belcher (ORCID: https://orcid.org/0000-0001-9652-9168)
- Mark Suett (ORCID: https://orcid.org/0000-0002-6840-1535)
- Dawn I. Velligan (ORCID: https://orcid.org/0000-0002-8213-1471)
- Kelli R. Franzenburg
Institutions
- The University of Texas at San Antonio Health Science Center (US)
- Health Outcomes Solutions (United States) (US)
- Teva Pharmaceuticals (United States) (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1186/s12888-025-06565-1
- Citations
- 4
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.88